Myriad Genetics Inc
XMUN:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
XMUN:MYD
|
US |
|
Barry Callebaut AG
F:BCLN
|
CH |
|
Teleperformance SE
F:RCF0
|
FR |
|
P
|
Puma SE
F:PUM
|
DE |
|
C
|
Citigroup Inc
XHAN:TRVC
|
US |
|
M
|
MTU Aero Engines AG
SWB:MTX
|
DE |
|
H
|
HEICO Corp
NYSE:HEI.A
|
US |
|
NextSource Materials Inc
TSX:NEXT
|
CA |
|
K
|
Kingspan Group PLC
XMUN:KRX
|
IE |
|
G
|
Gen Digital Inc
F:SYM
|
US |
|
EQT AB
STO:EQT
|
SE |
|
Bonduelle SA
F:BDU
|
FR |
|
I
|
Insperity Inc
F:ASF
|
US |
|
A
|
Alstom SA
DUS:AOMD
|
FR |
|
E
|
Enterprise Metals Ltd
F:RM9
|
AU |
|
Aston Martin Lagonda Global Holdings PLC
F:A5SA
|
UK |
|
N
|
Nippon Steel Corp
F:NPSA
|
JP |
|
B
|
British American Tobacco plc
F:BMT
|
UK |
|
P
|
Porn Prom Metal PCL
SET:PPM
|
TH |
|
C
|
CAE Inc
F:CE9
|
CA |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
637.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
252.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
211.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
95.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
59.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
50.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.7m USD. This includes both short-term (0 USD) and long-term (120.7m USD) debt.
You can find a full breakdown on its Balance Sheet.